Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Acumen Pharmaceuticals schedules two September 2026 fireside chats at major healthcare and biopharma investor conferences with live webcasts for investors.

Rhea-AI Summary

Acumen Pharmaceuticals (ABOS) will participate in two investor conferences in September 2026, featuring management fireside chats.

The company joins the Cantor Global Healthcare Conference 2026 on September 9, 2026 at 3:55 p.m. ET and Citi’s 2026 Biopharma Back to School Conference on September 10, 2026 at 8:40 a.m. ET. Live webcasts will be available on the company’s website under the Investors tab and archived for 90 days.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEWTON, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today that management will participate in the following upcoming investor conferences.

Cantor Global Healthcare Conference 2026

Date/Time: Fireside chat on Wednesday, September 9, 2026 at 3:55 p.m. ET

Citi’s 2026 Biopharma Back to School Conference

Date/Time: Fireside chat on Thursday, September 10, 2026 at 8:40 a.m. ET

The live webcasts may be accessed under the Investors tab on www.acumenpharm.com and will be archived for 90 days.

About Acumen Pharmaceuticals, Inc. 

Acumen Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD). Acumen’s scientific founders pioneered research on AβOs, which a growing body of evidence indicates are early and persistent triggers of Alzheimer’s disease pathology. Acumen is currently focused on advancing its lead investigational product candidate, sabirnetug (ACU193), a humanized monoclonal antibody that selectively targets toxic soluble AβOs, in its ongoing Phase 2 clinical trial ALTITUDE-AD (NCT06335173) in early symptomatic Alzheimer’s disease patients, following positive results in its Phase 1 trial INTERCEPT-AD. Acumen is also investigating a subcutaneous formulation of sabirnetug using Halozyme’s proprietary ENHANZE® drug delivery technology. Acumen is also collaborating with JCR Pharmaceuticals to develop an Enhanced Brain Delivery™ (EBD™) therapy for Alzheimer’s disease utilizing a transferrin-receptor-targeting blood-brain barrier-penetrating technology. The company is headquartered in Newton, Mass. For more information, visit www.acumenpharm.com.

Investors:
Alex Braun
abraun@acumenpharm.com 

Media: 
ICR Healthcare
AcumenPR@icrhealthcare.com 

FAQ

When will Acumen Pharmaceuticals (ABOS) present at the Cantor Global Healthcare Conference 2026?

Acumen Pharmaceuticals will participate in a fireside chat at the Cantor Global Healthcare Conference 2026 on Wednesday, September 9, 2026 at 3:55 p.m. ET. The session will be available via live webcast on the company’s website under the Investors tab.

What is the date and time of Acumen Pharmaceuticals (ABOS) appearance at Citi’s 2026 Biopharma Back to School Conference?

Acumen Pharmaceuticals is scheduled for a fireside chat at Citi’s 2026 Biopharma Back to School Conference on Thursday, September 10, 2026 at 8:40 a.m. ET. Investors can access the live webcast through the Investors section of the company’s website.

How can investors access the live webcasts of Acumen Pharmaceuticals (ABOS) September 2026 conference presentations?

The live webcasts of Acumen Pharmaceuticals’ September 2026 fireside chats can be accessed under the Investors tab at www.acumenpharm.com. The company states that these webcasts will be archived and available for replay for 90 days.

How long will replays of Acumen Pharmaceuticals (ABOS) 2026 conference webcasts be available?

Replays of Acumen Pharmaceuticals’ 2026 investor conference webcasts will be archived on the company’s website for 90 days. Investors can access them under the Investors tab following the live events at the Cantor Global Healthcare and Citi’s Biopharma Back to School conferences.